Bin Liu
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
Papers in
-
- Ubiquitin and proteasome pathways 41
- RNA modifications and cancer 31
- Epigenetics and DNA Methylation 21
- Surgery 82
- Pancreatic function and diabetes 15
- Co-authors
- Ke Shuai (5 shared papers)Pengli Wang (3 shared papers)Yang Xia (3 shared papers)Ming Yang (5 shared papers)Zhijun Zhang (1 shared paper)Gao‐Jun Teng (1 shared paper)Zhanlong Ma (1 shared paper)Hongying Zhang (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (10 papers)Diabetes (9 papers)Cell Death and Disease (7 papers)Frontiers in Pharmacology (7 papers)Scientific Reports (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bin Liu
469 papers receiving 9.5k citations
Bin Liu's Hit Papers
Peers
Comparison fields: 5 of 165
- Cancer Research 1.7k
- Molecular Biology 4.5k
- Oncology 1.1k
- Immunology 898
- Geriatrics and Gerontology 110
Countries citing papers authored by Bin Liu
This map shows the geographic impact of Bin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Liu more than expected).
Fields of papers citing papers by Bin Liu
This network shows the impact of papers produced by Bin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Liu. The network helps show where Bin Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 502 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 347 | |
| 2 | 2010 | 253 | |
| 3 | 2017 | 211 | |
| 4 | 2013 | 170 | |
| 5 | 2012 | 160 | |
| 6 | 2013 | 136 | |
| 7 | 2007 | 130 | |
| 8 | 2011 | 129 | |
| 9 | 2014 | 121 | |
| 10 | 2016 | 114 | |
| 11 | 2020 | 111 | |
| 12 | 2015 | 109 | |
| 13 | 2018 | 108 | |
| 14 | 2016 | 89 | |
| 15 | 2018 | 89 | |
| 16 | Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression Hit paper breakdown → | 2024 | 86 |
| 17 | 2013 | 78 | |
| 18 | 2014 | 74 | |
| 19 | 2017 | 73 | |
| 20 | 2010 | 72 |
About Bin Liu
Bin Liu is a scholar working on Molecular Biology, Surgery, Cancer Research, Epidemiology and Oncology, having authored 502 papers that have together received 9.6k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (41 papers), RNA modifications and cancer (31 papers), MicroRNA in disease regulation (30 papers), Cancer, Hypoxia, and Metabolism (24 papers), Epigenetics and DNA Methylation (21 papers), Cancer-related molecular mechanisms research (19 papers), Liver Disease Diagnosis and Treatment (18 papers) and Pancreatic function and diabetes (15 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (4.5k citations), Oncology (1.1k citations), Immunology (898 citations) and Geriatrics and Gerontology (110 citations). Bin Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ke Shuai, Pengli Wang, Yang Xia, Ming Yang, Zhijun Zhang, Gao‐Jun Teng, Zhanlong Ma, Hongying Zhang, Shijie Wang and Hong Jian. Their work appears in journals such as Biochemical and Biophysical Research Communications, Diabetes, Cell Death and Disease, Frontiers in Pharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.